User profiles for Jeffrey V Lazarus
Jeffrey V LazarusCUNY Graduate School of Public Health and Health Policy (CUNY SPH) Verified email at isglobal.org Cited by 68598 |
[HTML][HTML] A global survey of potential acceptance of a COVID-19 vaccine
Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June
2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates …
2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates …
[HTML][HTML] The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations
JV Lazarus, K Safreed-Harmon… - Seminars in liver …, 2018 - thieme-connect.com
The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World
Health Organization to define ambitious targets for eliminating HCV as a public health threat …
Health Organization to define ambitious targets for eliminating HCV as a public health threat …
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
…, CL Wai-cheung, J Layden, JV Lazarus… - The lancet …, 2018 - thelancet.com
Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (…
to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (…
[HTML][HTML] Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030
…, Y Eguchi, A Geier, LA Kondili, DC Kroy, JV Lazarus… - Journal of …, 2018 - Elsevier
Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis
(NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. …
(NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. …
Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies
The burden of liver disease in Europe continues to grow. We aimed to describe the epidemiology
of liver diseases and their risk factors in European countries, identifying public health …
of liver diseases and their risk factors in European countries, identifying public health …
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
…, J Howell, J Jia, N Kravchenko, JV Lazarus… - The lancet …, 2019 - thelancet.com
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual
mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV …
mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV …
[HTML][HTML] COVID-SCORE: A global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10)
Background Understanding public perceptions of government responses to COVID-19 may
foster improved public cooperation. Trust in government and population risk of exposure may …
foster improved public cooperation. Trust in government and population risk of exposure may …
[HTML][HTML] Pandemic publishing poses a new COVID-19 challenge
…, TH Andersen, LN Rasmussen, JV Lazarus - Nature Human …, 2020 - nature.com
The scientific community’s response to COVID-19 has resulted in a large volume of research
moving through the publication pipeline at extraordinary speed, with a median time from …
moving through the publication pipeline at extraordinary speed, with a median time from …
[HTML][HTML] The Lancet Commission on lessons for the future from the COVID-19 pandemic
…, M Hellard, UK Huynh, S Khandelwal, JV Lazarus… - The Lancet, 2022 - thelancet.com
As of May 31, 2022, there were 6· 9 million reported deaths and 17· 2 million estimated
deaths from COVID-19, as reported by the Institute for Health Metrics and Evaluation (IHME; …
deaths from COVID-19, as reported by the Institute for Health Metrics and Evaluation (IHME; …
[HTML][HTML] Advancing the global public health agenda for NAFLD: a consensus statement
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …
approximately one-quarter of the global adult population, causing a substantial burden of ill …